Formulation & Delivery Series UK
Upperton will be exhibiting at the Formulation & Delivery Series UK: VIRTUAL from Wednesday 8th to Thursday 9th July (UTC+1).
We are looking forward to meeting both new and existing clients on our stand. So if you have an API which requires formulation development or clinical manufacture, please contact us to book an appointment or alternatively drop by our exhibition stand to talk to Upperton’s team
Showcase Presentation, Thursday 9th July at 10.30 am
Upperton’s Founder & CEO, Richard Johnson will be presenting ‘Upperton Pharma Solutions: A Specialist CDMO’ on Thursday 9th July 10.30 am at the Formulation & Delivery Series UK: Virtual conference.
This talk will cover:
- History and recent growth
- Full scope of services
- What to expect when working with Upperton
Round-table Discussion, Thursday 9th July at 11.30 am
Upperton’s Technical Consultant will be hosting the round-table discussion ‘CDMO – Oral Drug Delivery Challenges During Early
Development’ on Thursday 9th July 11.30 am at the Formulation & Delivery Series UK: Virtual conference.
This round-table discussion will cover:
- What currently are the most common drug delivery challenges seen in the CDMO industry
- Oral bioavailability is obviously a big challenge what are key issues when selecting a suitable enabling technology
- Is there ever a case for by-passing formulation development and simply preparing a simple powder in capsule formulation for the first in human studies
Recent News at Upperton
Upperton have been investing in new equipment to enhance our capabilities in manufacturing final dosage forms. Our current focus is in enhancing / increasing out put in our tabletting capabilities. In 2019, Upperton acquired a new cutting edge tablet press, Futorque X by KG-Pharma which can produce up to 130,000 tablets per hour or supporting DoE and research studies with minimal material.
The O Hara LC M5 coater was also purchased in 2019; film coating is a key process offering a wide range of drug delivery benefits including: taste/odour masking, stability protection, modification of release profiles, ease of administration and product identification. Upperton will follow these investments through the purchase of further tabletting equipment.
The new service UpperSolv™ was launched in late 2019. UpperSolv™ is a signposted pathway to rapid, tailored screening of small quantities of API, the manufacture of prototype formulations using a range of scalable enabling technologies and comparison of the biopharmaceutical performance via a PK assessment.
The Formulation & Delivery Series UK
The Formulation & Delivery Series UK, combines the 6th Annual Formulation & Drug Delivery Congress, 5th Annual Inhalation & Respiratory Drug Delivery Congress and Biomanufacturing Congress. With over 300 influencers, experts and researchers attending to learn about the latest updates in biopharmaceutical advancements shaping the future of drug product development.